COVID-19住院患者的神经系统表现:ALBACOVID登记研究
该研究系统回顾了2020年3月西班牙一家医院收治的841例COVID-19住院患者,发现57.4%出现某种神经系统症状。肌痛、头痛、头晕多见于感染早期,嗅觉障碍和味觉障碍倾向早发且多见于轻症,意识障碍常见于老年重症患者。神经系统并发症占所有死亡患者的4.1%。
要点
- 超过半数COVID-19住院患者出现神经系统症状。
- 嗅觉障碍和味觉障碍常为首发表现且多见于轻症。
- 意识障碍常见于老年重症患者且提示病情进展。
核心结论
- 神经系统表现在COVID-19住院患者中常见,超过半数出现某种神经系统症状。
研究设计与样本
- 系统回顾2020年3月西班牙一家医院收治的841例COVID-19住院患者,分析人口学、临床和辅助检查资料。
主要发现
- 841例患者中57.4%出现神经系统症状,平均年龄66.4岁,男性占56.2%。
- 肌痛17.2%、头痛14.1%、头晕6.1%多见于感染早期。
- 嗅觉障碍4.9%和味觉障碍6.2%倾向早发,60%为首发表现,且多见于轻症。
- 意识障碍发生率为19.6%,多见于老年重症及晚期患者。
- 神经系统并发症占所有死亡患者的4.1%,为死亡主因。
临床怎么用
- 对COVID-19住院患者应保持密切神经系统监测以及时识别并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The coronavirus disease 2019 (COVID-19) has spread worldwide since December 2019. Neurologic symptoms have been reported as part of the clinical spectrum of the disease. We aimed to determine whether neurologic manifestations are common in hospitalized patients with COVID-19 and to describe their main characteristics. METHODS: We systematically reviewed all patients diagnosed with COVID-19 admitted to the hospital in a Spanish population during March 2020. Demographic characteristics, systemic and neurologic clinical manifestations, and complementary tests were analyzed. RESULTS: Of 841 patients hospitalized with COVID-19 (mean age 66.4 years, 56.2% men), 57.4% developed some form of neurologic symptom. Nonspecific symptoms such as myalgias (17.2%), headache (14.1%), and dizziness (6.1%) were present mostly in the early stages of infection. Anosmia (4.9%) and dysgeusia (6.2%) tended to occur early (60% as the first clinical manifestation) and were more frequent in less severe cases. Disorders of consciousness occurred commonly (19.6%), mostly in older patients and in severe and advanced COVID-19 stages. Myopathy (3.1%), dysautonomia (2.5%), cerebrovascular diseases (1.7%), seizures (0.7%), movement disorders (0.7%), encephalitis (n = 1), Guillain-Barré syndrome (n = 1), and optic neuritis (n = 1) were also reported, but less frequent. Neurologic complications were the main cause of death in 4.1% of all deceased study participants. CONCLUSIONS: Neurologic manifestations are common in hospitalized patients with COVID-19. In our series, more than half of patients presented some form of neurologic symptom. Clinicians need to maintain close neurologic surveillance for prompt recognition of these complications. The mechanisms and consequences of severe acute respiratory syndrome coronavirus type 2 neurologic involvement require further studies.
引用
- Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020. PMID: 32482845. doi:10.1212/WNL.0000000000009937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。